A new drug therapy for cancer treatment, spun out of research performed in a CU Boulder biochemistry lab, may provide better results for patients with solid cancers and hematologic cancers, such as leukemia and lymphoma.
Scientists do not fully understand how cells choose between proliferation and quiescence (a state of non-proliferation) but a University of Colorado Boulder biochemist’s novel proposal to study the issue has won the support of the National Institutes of Health (NIH).
